Life sciences SPAC European Biotech Acquisition files for a $100 million IPO

European Biotech Acquisition, a blank check company formed by LSP targeting the life sciences industry in Europe, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering.

The Amsterdam, Netherlands-based company plans to raise $100 million by ofRead More